Literature DB >> 12728637

The major diabetes prevention trials.

Jaakko Tuomilehto1, Jaana Lindström.   

Abstract

Type 2 diabetes (T2D) is a devastating disease with multiple complications affecting many tissues, most notably the cardiovascular system. To be able to prevent a chronic disease such as T2D, certain requirements have to be met. Knowledge about its natural history with a preclinical phase, modifiable risk factors, effective and simple screening tools to identify high-risk subjects, and effective intervention that is affordable and acceptable are necessary. In addition, the efficacy of the intervention has to be proven under a clinical trial setting. Several major lifestyle intervention trials have been successfully carried out, with consistent results: the risk of T2D in high-risk subjects can be halved, the effect of lifestyle changes is rapid, and benefits are similar in different ethnic groups. Thus, the prevention of T2D is possible in most high-risk subjects, but how to achieve this at the population level remains a major challenge.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12728637     DOI: 10.1007/s11892-003-0034-9

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  32 in total

1.  TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.

Authors:  S P Azen; R K Peters; K Berkowitz; S Kjos; A Xiang; T A Buchanan
Journal:  Control Clin Trials       Date:  1998-04

2.  Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?

Authors:  J E Shaw; P Z Zimmet; M de Courten; G K Dowse; P Chitson; H Gareeboo; F Hemraj; D Fareed; J Tuomilehto; K G Alberti
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

3.  The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

4.  The Diabetes Prevention Program (DPP): description of lifestyle intervention.

Authors: 
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

5.  The Finnish Diabetes Prevention Study.

Authors:  M Uusitupa; A Louheranta; J Lindström; T Valle; J Sundvall; J Eriksson; J Tuomilehto
Journal:  Br J Nutr       Date:  2000-03       Impact factor: 3.718

6.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

7.  Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults.

Authors:  D Dabelea; D J Pettitt; R L Hanson; G Imperatore; P H Bennett; W C Knowler
Journal:  Diabetes Care       Date:  1999-06       Impact factor: 19.112

8.  The diabetes risk score: a practical tool to predict type 2 diabetes risk.

Authors:  Jaana Lindström; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

9.  Increasing prevalence of Type II diabetes in American Indian children.

Authors:  D Dabelea; R L Hanson; P H Bennett; J Roumain; W C Knowler; D J Pettitt
Journal:  Diabetologia       Date:  1998-08       Impact factor: 10.122

10.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

View more
  5 in total

1.  The twin epidemics of poverty and diabetes: understanding diabetes disparities in a low-income Latino and immigrant neighborhood.

Authors:  Claudia Chaufan; Meagan Davis; Sophia Constantino
Journal:  J Community Health       Date:  2011-12

Review 2.  Risk models and scores for type 2 diabetes: systematic review.

Authors:  Douglas Noble; Rohini Mathur; Tom Dent; Catherine Meads; Trisha Greenhalgh
Journal:  BMJ       Date:  2011-11-28

3.  Evolutionary origins of insulin resistance: a behavioral switch hypothesis.

Authors:  Milind G Watve; Chittaranjan S Yajnik
Journal:  BMC Evol Biol       Date:  2007-04-17       Impact factor: 3.260

4.  Incremental predictive value of screening for anxiety and depression beyond current type 2 diabetes risk models: a prospective cohort study.

Authors:  Evan Atlantis; Shima Ghassem Pour; Federico Girosi
Journal:  BMJ Open       Date:  2018-01-23       Impact factor: 2.692

Review 5.  Mitochondrial Dysfunction-Associated Arrhythmogenic Substrates in Diabetes Mellitus.

Authors:  Jiajia Song; Ruilin Yang; Jing Yang; Lufang Zhou
Journal:  Front Physiol       Date:  2018-12-06       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.